Hangzhou Tigermed Consulting Co., Ltd (HKG:3347)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Clinical Trial Technical Services	4.17B
Clinical Trial Technical Services Growth	1.04%
Clinical Trial-related Services and Laboratory Services	3.12B
Clinical Trial-related Services and Laboratory Services Growth	8.51%
Other Business	94.93M
Other Business Growth	13.10%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	4.23B
China Growth	17.57%
Overseas	3.15B
Overseas Growth	-9.60%